FDA Drug Application (021782) for ROZEREM by TAKEDA PHARMS USA

Back to FDA Applications sponsored by TAKEDA PHARMS USA

Application Number021782
Product Number001
FormTABLET;ORAL
Dosage8MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameROZEREM
Active IngredientRAMELTEON

Active IngredientCount
List of drugs with Active Ingredient RAMELTEON2


Back to FDA Applications sponsored by TAKEDA PHARMS USA